Pyolytics as a product of the physical–chemical repurposing of antiseptics and an alternative to larval therapy for chronic wounds

Abstract

The traditional treatment of chronic wounds involves daily cleansing of the wound surface from purulent necrotic masses using mechanical and medicinal methods, accompanied by regular replacement of wound dressing. In this case, medicinal wound cleansing lasts 10–15 mins from the time of replacement of the old wound dressing with the new one. According to established practice, medicinal sanitation of infected and purulent wounds during dressing involves irrigation of the wound surface with cleansing solutions, antiseptics, and/or antibiotics. In severe cases, the above therapy is supplemented with live larvae of the necrophage fly, which are injected into purulent necrotic masses and left in them under wound dressing until wounds are completely cleansed from pus. Nevertheless, the generally accepted course of treatment of chronic wounds remains ineffective. The use of pyolytics and their supplementation with wound dressings in the form of warm wet compresses, which create a local greenhouse effect in wounds, was reported to accelerate the healing of chronic wounds. Pyolytics are a group of antiseptics developed in Russia. They are warm alkaline solutions of hydrogen peroxide; when they interact with purulent necrotic masses, these solutions dissolve very quickly and foam them. Because of the interaction with pyolytics, thick purulent masses immediately turn into fluffy oxygenated foam. Pyolytics have been developed because of the physicochemical repurposing of aqueous solutions of sodium hydrogen carbonate and hydrogen peroxide. To accelerate the healing of chronic wounds, a recommendation was to irrigate the surface of chronic wounds with 3% hydrogen peroxide and 2–10% sodium bicarbonate solutions, heated to 37–45°C, which have alkaline activity at pH 8.4–8.5 and are enriched with dissolved carbon dioxide or oxygen (due to excess pressure of 0.2 atm). This study presented the importance of treating chronic wounds using politics and treatment outcomes using pyolytics along with warm moist dressing compresses, demonstrating a wound-healing effect. Consequently, physical and chemical reprofiling of antiseptics may make them effective pyolytics, and the combination of pyolytics with warm wound dressings such as warm moist compresses, which create a local greenhouse effect on wounds, accelerates the healing of chronic wounds.

Keywords

physical–chemical repurposing / antiseptics / wound dressings / purulent masses / chronic wounds / wound healing / localized hyperthermia

References

[1] Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2(3):165–170. DOI: 10.1046/j.1524-475X.1994.20305.x

[2] Lazarus G.S., Cooper D.M., Knighton D.R., et al. Definitions and guidelines for assessment of wounds and evaluation of healing // Wound Repair Regen. 1994. Vol. 2, No. 3. P. 165–170. DOI: 10.1046/j.1524-475X.1994.20305.x

[3] Shahrousvand M, Mirmasoudi SS, Pourmohammadi-Bejarpasi Z, et al. Polyacrylic acid/ polyvinylpyrrolidone hydrogel wound dressing containing zinc oxide nanoparticles promote wound healing in a rat model of excision injury. Heliyon, 2023;9(8):e19230.

[4] Shahrousvand M., Mirmasoudi S.S., Pourmohammadi-Bejarpasi Z., et al. Polyacrylic acid/ polyvinylpyrrolidone hydrogel wound dressing containing zinc oxide nanoparticles promote wound healing in a rat model of excision injury // Heliyon. 2023. Vol. 9, No. 8. P. e19230.

[5] Sharma AD, Jarman EH, Fox PM. Scoping review of hydrogel therapies in the treatment of diabetic chronic wounds. Plast Reconstr Surg Glob Open. 2023;11(5):e4984.

[6] Sharma A.D., Jarman E.H., Fox P.M. Scoping review of hydrogel therapies in the treatment of diabetic chronic wounds // Plast Reconstr Surg Glob Open. 2023. Vol. 11, No. 5. P. e4984.

[7] Lee CH, Chen DY, Hsieh MJ, et al. Nanofibrous insulin/vildagliptin core-shell PLGA scaffold promotes diabetic wound healing. Front Bioeng Biotechnol. 2023;11:1075720. DOI: 10.3389/fbioe.2023.1075720

[8] Lee C.H., Chen D.Y., Hsieh M.J., et al. Nanofibrous insulin/vildagliptin core-shell PLGA scaffold promotes diabetic wound healing // Front Bioeng Biotechnol. 2023. Vol. 11. P. 1075720. DOI: 10.3389/fbioe.2023.1075720

[9] InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65083/

[10] Ganod WAM. Chronic Venous Ulcer. 2022. IntechOpen. DOI: 10.5772/intechopen.97709

[11] Ganod W.A.M. Chronic Venous Ulcer. 2022 // IntechOpen. DOI: 10.5772/intechopen.97709

[12] Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Advances in Wound Care. 2015;4(9):560–582. DOI: 10.1089/wound.2015.0635

[13] Frykberg R.G., Banks J. Challenges in the treatment of chronic wounds // Advances in Wound Care. 2015. Vol. 4, No. 9. P. 560–582. DOI: 10.1089/wound.2015.0635

[14] O’Connor T, Moore ZE, Patton D. Patient and lay carer education for preventing pressure ulceration in at-risk populations. Cochrane Database Syst Rev. 2021;2(2):CD012006. DOI: 10.1002/14651858.CD012006.pub2

[15] O’Connor T., Moore Z.E., Patton D. Patient and lay carer education for preventing pressure ulceration in at-risk populations // Cochrane Database Syst Rev. 2021. Vol. 2, No. 2. P. CD012006. DOI: 10.1002/14651858.CD012006.pub2

[16] Shanley E, Patton D, Avsar P, et al. The impact of the Shanley Pressure Ulcer Prevention Programme on older persons’ knowledge of, and attitudes and behaviours towards, pressure ulcer prevention. Int Wound J. 2022;19(4):754–764. DOI: 10.1111/iwj.13671

[17] Shanley E., Patton D., Avsar P., et al. The impact of the Shanley Pressure Ulcer Prevention Programme on older persons’ knowledge of, and attitudes and behaviours towards, pressure ulcer prevention // Int Wound J. 2022. Vol. 19, No. 4. P. 754–764. DOI: 10.1111/iwj.13671

[18] Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic Foot Ulcers: A Review. JAMA. 2023;330(1):62–75. DOI: 10.1001/jama.2023.10578

[19] Armstrong D.G., Tan T.W., Boulton A.J.M., Bus S.A. Diabetic Foot Ulcers: A Review // JAMA. 2023. Vol. 330, No. 1. P. 62–75. DOI: 10.1001/jama.2023.10578

[20] Minty E, Bray E, Bachus CB, et al. Preventative sensor-based remote monitoring of the diabetic foot in clinical practice. Sensors (Basel). 2023;23(15):6712. DOI: 10.3390/s23156712

[21] Minty E., Bray E., Bachus C.B., et al. Preventative sensor-based remote monitoring of the diabetic foot in clinical practice // Sensors (Basel). 2023. Vol. 23, No. 15. P. 6712. DOI: 10.3390/s23156712

[22] Järbrink K, Ni G, Sönnergren H, et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review. Syst Rev. 2017;6(1):15.

[23] Järbrink K., Ni G., Sönnergren H., et al. The humanistic and economic burden of chronic wounds: a protocol for a systematic review // Syst Rev 2017. Vol. 6, No. 1. P. 15.

[24] Ruiz PBO, Lima AFC. Average direct costs of outpatient, hospital, and home care provided to patients with chronic wounds. Rev Esc Enferm USP. 2022;56:e20220295. DOI: 10.1590/1980-220X-REEUSP-2022-0295en

[25] Ruiz P.B.O., Lima A.F.C. Average direct costs of outpatient, hospital, and home care provided to patients with chronic wounds // Rev Esc Enferm USP. 2022. Vol. 56. P. e20220295. DOI: 10.1590/1980-220X-REEUSP-2022-0295en

[26] Tatarusanu SM, Lupascu FG, Profire BS, et al. Modern Approaches in Wounds Management. Polymers (Basel). 2023;15(17):3648. DOI: 10.3390/polym15173648

[27] Tatarusanu S.M., Lupascu F.G., Profire B.S., et al. Modern approaches in wounds management // Polymers (Basel). 2023. Vol. 15, No. 17. P. 3648. DOI: 10.3390/polym15173648

[28] Phillips CJ, Humphreys I, Fletcher J, et al. Estimating the costs associated with the management of patients with chronic wounds using linked routine data. Int Wound J. 2016;13(6):1193–1197. DOI: 10.1111/iwj.12443

[29] Phillips C.J., Humphreys I., Fletcher J., et al. Estimating the costs associated with the management of patients with chronic wounds using linked routine data // Int Wound J. 2016. Vol. 13, No. 6. P. 1193–1197. DOI: 10.1111/iwj.12443

[30] Urakov AL, Urakova N, Fisher E, et al. Antiseptic pyolytics and warming wet compresses improve the prospect of healing chronic wounds. Explor Med. 2023;4:747–754. DOI: 10.37349/emed.2023.00175

[31] Urakov A.L., Urakova N., Fisher E., et al. Antiseptic pyolytics and warming wet compresses improve the prospect of healing chronic wounds // Explor Med. 2023. Vol. 4. P. 747–754. DOI: 10.37349/emed.2023.00175

[32] Serra R, Grande R, Butrico L, et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther. 2015;13(5):605–613. DOI: 10.1586/14787210.2015.1023291

[33] Serra R., Grande R., Butrico L., et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus // Expert Rev Anti Infect Ther. 2015. Vol. 13, No. 5. P. 605–613. DOI: 10.1586/14787210.2015.1023291

[34] Cwajda-Białasik J, Mościcka P, Szewczyk M. Antiseptics and antimicrobials for the treatment and management of chronic wounds: a systematic review of clinical trials. Postepy Dermatol Alergol. 2022;39(1):141–151. DOI: 10.5114/ada.2022.113807

[35] Cwajda-Białasik J., Mościcka P., Szewczyk M. Antiseptics and antimicrobials for the treatment and management of chronic wounds: a systematic review of clinical trials // Postepy Dermatol Alergol. 2022. Vol. 39, No. 1. P. 141–151. DOI: 10.5114/ada.2022.113807

[36] Rembe JD, Huelsboemer L, Plattfaut I, et al. Antimicrobial hypochlorous wound irrigation solutions demonstrate lower anti-biofilm efficacy against bacterial biofilm in a complex in-vitro human plasma biofilm model (hpBIOM) than common wound antimicrobials. Front Microbiol. 2020;11:564513. DOI: 10.3389/fmicb.2020.564513

[37] Rembe J.D., Huelsboemer L., Plattfaut I., et al. Antimicrobial hypochlorous wound irrigation solutions demonstrate lower anti-biofilm efficacy against bacterial biofilm in a complex in-vitro human plasma biofilm model (hpBIOM) than common wound antimicrobials // Front Microbiol. 2020. Vol. 11. P. 564513. DOI: 10.3389/fmicb.2020.564513

[38] O’Meara S, Al-Kurdi D, Ologun Y, et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2013;(12): CD003557. DOI: 10.1002/14651858.CD003557.pub4

[39] O’Meara S., Al-Kurdi D., Ologun Y., et al. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 2013. No. 12. P. CD003557. DOI: 10.1002/14651858.CD003557.pub4

[40] Davidson E, Pereira J, Gan Giannelli G, et al. Multi-functional chitosan nanovesicles loaded with bioactive manganese for potential wound healing applications. Molecules. 2023;28(16):6098. DOI: 10.3390/molecules28166098

[41] Davidson E., Pereira J., Gan Giannelli G., et al. Multi-functional chitosan nanovesicles loaded with bioactive manganese for potential wound healing applications // Molecules. 2023. Vol. 28, No. 16. P. 6098. DOI: 10.3390/molecules28166098

[42] Turzańska K, Adesanya O, Rajagopal A, et al. Improving the management and treatment of diabetic foot infection: Challenges and research opportunities. Int J Mol Sci. 2023;24(4):3913. DOI: 10.3390/ijms24043913

[43] Turzańska K., Adesanya O., Rajagopal A., et al. Improving the management and treatment of diabetic foot infection: Challenges and research opportunities // Int J Mol Sci. 2023. Vol. 24, No. 4. P. 3913. DOI: 10.3390/ijms24043913

[44] Husain M, Agrawal YO. Antimicrobial remedies and emerging strategies for the treatment of diabetic foot ulcers. Curr Diabetes Rev. 2023;19(5):e280222201513. DOI: 10.2174/1573399818666220228161608

[45] Husain M., Agrawal Y.O. Antimicrobial remedies and emerging strategies for the treatment of diabetic foot ulcers // Curr Diabetes Rev. 2023. Vol. 19, No. 5. P. e280222201513. DOI: 10.2174/1573399818666220228161608

[46] Mostafalu P, Tamayol A, Rahimi R, et al. Smart bandage for monitoring and treatment of chronic wounds. Small. 2018;14:1703509.

[47] Mostafalu P., Tamayol A., Rahimi R., et al. Smart bandage for monitoring and treatment of chronic wounds // Small. 2018. Vol. 14. P. 1703509.

[48] Kim M. Antiseptics and cleansing the chronic wound: Best practice. Journal of Wound Management and Research. 2023;19(1):8–12. DOI: 10.22467/jwmr.2023.02404

[49] Kim M. Antiseptics and cleansing the chronic wound: Best practice // Journal of Wound Management and Research. 2023. Vol. 19, No. 1. P. 8–12. DOI: 10.22467/jwmr.2023.02404

[50] Shi C, Wang C, Liu H, et al. Selection of appropriate wound dressing for various wounds. Front Bioeng Biotechnol. 2020;8:182. DOI: 10.3389/fbioe.2020.00182

[51] Shi C., Wang C., Liu H., et al. Selection of appropriate wound dressing for various wounds // Front Bioeng Biotechnol. 2020. Vol. 8. P. 182. DOI: 10.3389/fbioe.2020.00182

[52] Zhong D, Zhang H, Ma Z, et al. Recent advancements in wound management: Tailoring superwettable bio-interfaces. Front Bioeng Biotechnol. 2022;10:1106267. DOI: 10.3389/fbioe.2022.1106267

[53] Zhong D., Zhang H., Ma Z., et al. Recent advancements in wound management: Tailoring superwettable bio-interfaces // Front Bioeng Biotechnol. 2022. Vol. 10. P. 1106267. DOI: 10.3389/fbioe.2022.1106267

[54] Westby MJ, Dumville JC, Soares MO, et al. Dressings and topical agents for treating pressure ulcers. Cochrane Database Syst Rev. 2017;6(6):CD011947. DOI: 10.1002/14651858.CD011947.pub2

[55] Westby M.J., Dumville J.C., Soares M.O., et al. Dressings and topical agents for treating pressure ulcers // Cochrane Database Syst Rev. 2017. Vol. 6, No. 6. P. CD011947. DOI: 10.1002/14651858.CD011947.pub2

[56] Norman G, Westby MJ, Rithalia AD, et al. Dressings and topical agents for treating venous leg ulcers. Cochrane Database Syst Rev. 2018;6(6):CD012583. DOI: 10.1002/14651858.CD012583.pub2

[57] Norman G., Westby M.J., Rithalia A.D., et al. Dressings and topical agents for treating venous leg ulcers // Cochrane Database Syst Rev. 2018. Vol. 6, No. 6. P. CD012583. DOI: 10.1002/14651858.CD012583.pub2

[58] Zhang C, Zhang S, Wu B, et al. Efficacy of different types of dressings on pressure injuries: Systematic review and network meta-analysis. Nurs Open. 2023;10(9):5857–5867. DOI: 10.1002/nop2.1867

[59] Zhang C., Zhang S., Wu B., et al. Efficacy of different types of dressings on pressure injuries: Systematic review and network meta-analysis // Nurs Open. 2023. Vol. 10, No. 9. P. 5857–5867. DOI: 10.1002/nop2.1867

[60] Walker RM, Gillespie BM, Thalib L, et al. Foam dressings for treating pressure ulcers. Cochrane Database Syst Rev. 2017;10(10): CD011332. DOI: 10.1002/14651858.CD011332.pub2

[61] Walker R.M., Gillespie B.M., Thalib L., et al. Foam dressings for treating pressure ulcers // Cochrane Database Syst Rev. 2017. Vol. 10, No. 10. P. CD011332. DOI: 10.1002/14651858.CD011332.pub2

[62] Ahmad N. In vitro and in vivo characterization methods for evaluation of modern wound dressings. Pharmaceutics. 2022;15(1):42. DOI: 10.3390/pharmaceutics15010042

[63] Ahmad N. In vitro and in vivo characterization methods for evaluation of modern wound dressings // Pharmaceutics. 2022. Vol. 15, No. 1. P. 42. DOI: 10.3390/pharmaceutics15010042

[64] Powers JG, Morton LM, Phillips TJ. Dressings for chronic wounds. Dermatol Ther. 2013;26(3):197–206. DOI: 10.1111/dth.12055

[65] Powers J.G., Morton L.M., Phillips T.J. Dressings for chronic wounds // Dermatol Ther. 2013. Vol. 26, No. 3. P. 197–206. DOI: 10.1111/dth.12055

[66] Liang Y, Liang Y, Zhang H, Guo B. Antibacterial biomaterials for skin wound dressing. Asian J Pharm Sci. 2022;17(3):353–384. DOI: 10.1016/j.ajps.2022.01.001

[67] Liang Y., Liang Y., Zhang H., Guo B. Antibacterial biomaterials for skin wound dressing // Asian J Pharm Sci. 2022. Vol. 17, No. 3. P. 353–384. DOI: 10.1016/j.ajps.2022.01.001

[68] Morris D, Flores M, Harris L, et al. Larval therapy and larval excretions/secretions: A potential treatment for biofilm in chronic wounds? A systematic review. Microorganisms. 2023;11(2):457. DOI: 10.3390/microorganisms11020457

[69] Morris D., Flores M., Harris L., et al. Larval therapy and larval excretions/secretions: A potential treatment for biofilm in chronic wounds? A systematic review // Microorganisms. 2023. Vol. 11, No. 2. P. 457. DOI: 10.3390/microorganisms11020457

[70] Baer WS. The classic: The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). 1931. Clin Orthop Relat Res. 2011;469(4):920–944. DOI: 10.1007/s11999-010-1416-3

[71] Baer W.S. The classic: The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). 1931 // Clin Orthop Relat Res. 2011. Vol. 469, No. 4. P. 920–944. DOI: 10.1007/s11999-010-1416-3

[72] Markiewicz-Gospodarek A, Kozioł M, Tobiasz M, et al. Burn wound healing: Clinical complications, medical care, treatment, and dressing types: The current state of knowledge for clinical practice. Int J Environ Res Public Health. 2022;19(3):1338. DOI: 10.3390/ijerph19031338

[73] Markiewicz-Gospodarek A., Kozioł M., Tobiasz M., et al. Burn wound healing: Clinical complications, medical care, treatment, and dressing types: The current state of knowledge for clinical practice // Int J Environ Res Public Health. 2022. Vol. 19, No. 3. P. 1338. DOI: 10.3390/ijerph19031338

[74] Turkmen A, Graham K, McGrouther DA. Therapeutic applications of the larvae for wound debridement. J Plast Reconstr Aesthet Surg. 2010;63(1):184–188. DOI: 10.1016/j.bjps.2008.08.070

[75] Turkmen A., Graham K., McGrouther D.A. Therapeutic applications of the larvae for wound debridement // J Plast Reconstr Aesthet Surg. 2010. Vol. 63, No. 1. P. 184–188. DOI: 10.1016/j.bjps.2008.08.070

[76] Kenawy MA, Abdel-Hamid YM. Maggot therapy “Use of fly larvae for treatment of wounds” — A review. Egypt Acad J Biolog Sci. 2020;12(2):1–10. DOI: 10.21608/eajbse.2020.104166

[77] Kenawy M.A., Abdel-Hamid Y.M. Maggot therapy “Use of fly larvae for treatment of wounds” — A review // Egypt Acad J Biolog Sci. 2020. Vol. 12, No. 2. P. 1–10. DOI: 10.21608/eajbse.2020.104166

[78] Bazaliński D, Kózka M, Karnas M, Więch P. Effectiveness of chronic wound debridement with the use of larvae of lucilia sericata. J Clin Med. 2019;8(11):1845. DOI: 10.3390/jcm8111845

[79] Bazaliński D., Kózka M., Karnas M., Więch P. Effectiveness of chronic wound debridement with the use of larvae of Lucilia sericata // J Clin Med. 2019. Vol. 8, No. 11. P. 1845. DOI: 10.3390/jcm8111845

[80] Yusuf MA, Ibrahim BM, Oyebanji AA, et al. Maggot debridement therapy and complementary wound care: a case series from Nigeria. J Wound Care. 2022;31(11):996–1005. DOI: 10.12968/jowc.2022.31.11.996

[81] Yusuf M.A., Ibrahim B.M., Oyebanji A.A., et al. Maggot debridement therapy and complementary wound care: a case series from Nigeria // J Wound Care. 2022. Vol. 31, No. 11. P. 996–1005. DOI: 10.12968/jowc.2022.31.11.996

[82] Ribeiro CTD, Dias FAL, Fregonezi GAF. Hydrogel dressings for venous leg ulcers. Cochrane Database of Systematic Reviews. 2022;8(8):CD010738. DOI: 10.1002/14651858.CD010738.pub2

[83] Ribeiro C.T.D., Dias F.A.L., Fregonezi G.A.F. Hydrogel dressings for venous leg ulcers // Cochrane Database of Systematic Reviews. 2022. Vol. 8, No. 8. P. CD010738. DOI: 10.1002/14651858.CD010738.pub2

[84] King C. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion. J Wound Care. 2020;29(Sup2c):S28–S34. DOI: 10.12968/jowc.2020.29.Sup2c.S28

[85] King C. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion // J Wound Care. 2020. Vol. 29, No. Sup2c. P. S28–S34. DOI: 10.12968/jowc.2020.29.Sup2c.S28

[86] Parizad N, Hajimohammadi K, Goli R, et al. Surgical debridement and maggot debridement therapy (MDT) bring the light of hope to patients with diabetic foot ulcers (DFUs): A case report. Int J Surg Case Rep. 2022;99:107723. DOI: 10.1016/j.ijscr.2022.107723

[87] Parizad N., Hajimohammadi K., Goli R., et al. Surgical debridement and maggot debridement therapy (MDT) bring the light of hope to patients with diabetic foot ulcers (DFUs): A case report // Int J Surg Case Rep. 2022. Vol. 99. P. 107723. DOI: 10.1016/j.ijscr.2022.107723

[88] Urakov AL. Pus solvents as new drugs with unique physical and chemical property. Reviews on Clinical Pharmacology and Drug Therapy. 2019;17(4):89–95. DOI: 10.17816/RCF17489-95

[89] Ураков А.Л. Растворители гноя как новые лекарственные средства с уникальными физико-химическими свойствами // Обзоры по клинической фармакологии и лекарственной терапии. 2019. Т. 17, № 4. С. 89–95. DOI: 10.17816/RCF17489-95

[90] Urakov AL, Urakova NA, Urakova TV. New group of drugs: solvent of pus. Mezhdunarodnyi zhurnal prikladnykh i fundamental’nykh issledovanii. 2016;6:881–883.

[91] Ураков А.Л., Ураков Н.А., Уракова Т.В. Новая группа лекарств: растворители гноя // Международный журнал прикладных и фундаментальных исследований. 2016. Т. 6. C. 881–883.

[92] Bodduluri VP, Gurevich KG, Urakov AL. Physico-chemical properties of antiseptics in surgery: What is not taken into account in treating long-term non-healing wounds. Creative Surgery and Oncology. 2021;11(3):256–259.

[93] Bodduluri V.P., Gurevich K.G., Urakov A.L. Physico-chemical properties of antiseptics in surgery: What is not taken into account in treating long-term non-healing wounds // Creative Surgery and Oncology. 2021. Vol. 11, No. 3. P. 256–259.

[94] Gemma PA, Alejandro BA, Enric TBJ. Larval Therapy for treatment of chronic wounds colonized by multi-resistant pathogens in a pediatric patient: A case study. Journal of Wound, Ostomy and Continence Nursing. 2022;49(4):373–378. DOI: 10.1097/WON.0000000000000893

[95] Gemma P.A., Alejandro B.A., Enric T.B.J. Larval Therapy for treatment of chronic wounds colonized by multi-resistant pathogens in a pediatric patient: A case study // Journal of Wound, Ostomy and Continence Nursing. 2022. Vol. 49, No. 4. P. 373–378. DOI: 10.1097/WON.0000000000000893

[96] Fisher EL, Urakov AL, Samorodov AV, et al. Alkaline hydrogen peroxide solutions: expectorant, pyolytic, mucolytic, haemolytic, oxygen-releasing, and decolorizing effects. Reviews on Clinical Pharmacology and Drug Therapy. 2023;21(2):135–150. DOI: 10.17816/RCF492316

[97] Фишер Е.Л., Ураков А.Л., Самородов А.В., и др. Щелочные растворы перекиси водорода с отхаркивающим, пиолитическим, муколитическим, гемолитическим, кислород-освобождающим и обесцвечивающим действием // Обзоры по клинической фармакологии и лекарственной терапии. 2023. Т. 21, № 2. C. 135–150. DOI: 10.17816/RCF492316

[98] Urakov A, Urakova N, Shabanov P, et al. Suffocation in asthma and COVID-19: Supplementation of inhaled corticosteroids with alkaline hydrogen peroxide as an alternative to ECMO. Preprints.org 2023. 2023070627.

[99] Urakov A., Urakova N., Shabanov P., et al. Suffocation in asthma and COVID-19: Supplementation of inhaled corticosteroids with alkaline hydrogen peroxide as an alternative to ECMO // Preprints.org. 2023. 2023070627.

[100] Urakov AL, Shabanov PD. Physical-chemical repurposing of drugs. History of its formation in Russia. Reviews on Clinical Pharmacology and Drug Therapy. 2023;21(3):241–242. DOI: 10.17816/RCF567782

[101] Ураков А.Л., Шабанов П.Д. Физико-химическое перепрофилирование лекарств. История формирования его в России // Обзоры по клинической фармакологии и лекарственной терапии. 2023. Т. 21, № 3. C. 241–242. DOI: 10.17816/RCF567782

[102] Urakov AL. Method and technology of reprofiling drugs based on changes in the physico-chemical properties of dosage forms: experience of use in Russia. Psychopharmacology & Biological Narcology. 2023;14(3):203–208. DOI: 10.17816/phbn567970

[103] Ураков А.Л. Метод и технология перепрофилирования лекарств на основе изменения физико-химических свойств лекарственных форм: опыт использования в России // Психофармакология и биологическая наркология. 2023. Т. 14, № 3. C. 203–208. DOI: 10.17816/phbn567970

[104] Urakov A, Urakova N, Reshetnikov A, et al. Reprofiling Hydrogen peroxide from antiseptics to pyolytics: A narrative overview of the history of inventions in Russia. Journal of Pharmaceutical Research International. 2023;35(6):37–48. DOI: 10.9734/jpri/2023/v35i67333

[105] Urakov A., Urakova N., Reshetnikov A., et al. Reprofiling Hydrogen peroxide from antiseptics to pyolytics: A narrative overview of the history of inventions in Russia // Journal of Pharmaceutical Research International. 2023. Vol. 35, No. 6. P. 37–48. DOI: 10.9734/jpri/2023/v35i67333

[106] Urakov A, Urakova N, Sorokina Yu, et al. Targeted modification of physical-chemical properties of drugs as a universal way to transform “old” drugs into “new” drugs. In: Drug Repurposing — Advances, Scopes and Opportunities in Drug Discovery. Chapter 3. Ed. Dr. Mithun Rudrapal. March 2023. DOI: 10.5772/intechopen.110480

[107] Urakov A., Urakova N., Sorokina Yu., et al. Targeted modification of physical-chemical properties of drugs as a universal way to transform “old” drugs into “new” drugs. In: Drug Repurposing — Advances, Scopes and Opportunities in Drug Discovery. Chapter 3. Ed. Dr. Mithun Rudrapal. March 2023. DOI: 10.5772/intechopen.110480

[108] Urakov AL. The change of physical-chemical factors of the local interaction with the human body as the basis for the creation of materials with new properties. Journal of Silicate Based and Composite Materials. 2015;67(1):2–6. DOI: 10.14382/epitoanyag-jsbcm.2015.1

[109] Urakov A.L. The change of physical-chemical factors of the local interaction with the human body as the basis for the creation of materials with new properties // Journal of Silicate Based and Composite Materials. 2015. Vol. 67, No. 1. P. 2–6. DOI: 10.14382/epitoanyag-jsbcm.2015.1

[110] Shaikh DM, Shaikh HZ. Ash as a unique natural medicine for wound healing. Isra Medical Journal. 2009;1(3):72–78.

[111] Shaikh D.M., Shaikh H.Z. Ash as a unique natural medicine for wound healing // Isra Medical Journal. 2009. Vol. 1, No. 3. P. 72–78.

[112] Nagpal BM, Katoch R, Rajagopalan S. Wound healing — A surgical fundamental revisited. Med J Armed Forces India. 2002;58(3): 190–191. DOI: 10.1016/S0377-1237(02)80126-5

[113] Nagpal B.M., Katoch R., Rajagopalan S. Wound healing — A surgical fundamental revisited // Med J Armed Forces India. 2002. Vol. 58, No. 3. P. 190–191. DOI: 10.1016/S0377-1237(02)80126-5

[114] Hyper-hydration: a new perspective on wound cleansing, debridement and healing. Br J Community Nurs. 2016;21(S6): S26–S28. DOI: 10.12968/bjcn.2016.21.Sup6.S26

[115] Hyper-hydration: a new perspective on wound cleansing, debridement and healing // Br J Community Nurs. 2016. Vol. 21, No. S6. P. S26–S28. DOI: 10.12968/bjcn.2016.21.Sup6.S26

[116] Rippon MG, Ousey K, Cutting KF. Wound healing and hyper-hydration: a counterintuitive model. J Wound Care. 2016;25(2):68–75. DOI: 10.12968/jowc.2016.25.2.68

[117] Rippon M.G., Ousey K., Cutting K.F. Wound healing and hyper-hydration: a counterintuitive model // J Wound Care. 2016. Vol. 25, No. 2. P. 68–75. DOI: 10.12968/jowc.2016.25.2.68

[118] Saha S. Hybrid regenerative therapy for successful reconstruction of an infected traumatized diabetic foot wound. Plast Reconstr Surg Glob Open. 2023;11(8):e5213. DOI: 10.1097/GOX.0000000000005213

[119] Saha S. Hybrid regenerative therapy for successful reconstruction of an infected traumatized diabetic foot wound // Plast Reconstr Surg Glob Open. 2023. Vol. 11, No. 8. P. e5213. DOI: 10.1097/GOX.0000000000005213

[120] Urakov A, Urakova N, Reshetnikov A. Oxygen alkaline dental’s cleaners from tooth plaque, food debris, stains of blood and pus: A narrative review of the history of inventions. J Int Soc Prev Community Dent. 2019;9(5):427–433. DOI: 10.4103/jispcd.JISPCD_296_19

[121] Urakov A., Urakova N., Reshetnikov A. Oxygen alkaline dental’s cleaners from tooth plaque, food debris, stains of blood and pus: A narrative review of the history of inventions // J Int Soc Prev Community Dent. 2019. Vol. 9, No. 5. P. 427–433. DOI: 10.4103/jispcd.JISPCD_296_19

[122] Urakov AL. Creation of “necessary” mixtures of baking soda, hydrogen peroxide and warm water as a strategy for modernization bleaching cleaners of ceramic. Journal of Silicate Based and Composite Materials. 2020;72(1):30–35. DOI: 10.14382/epitoanyag-jsbcm.2020.6

[123] Urakov A.L. Creation of “necessary” mixtures of baking soda, hydrogen peroxide and warm water as a strategy for modernization bleaching cleaners of ceramic // Journal of Silicate Based and Composite Materials. 2020. Vol. 72, No. 1. P. 30–35. DOI: 10.14382/epitoanyag-jsbcm.2020.6

[124] Urakov AL, Urakova NA, et al. COVID-19: Artificial sputum, respiratory obstruction method and screening of pyolitic and antihypoxic drugs. BioImpacts. 2022;12(4):393–394. DOI: 10.34172/bi.2022.23877

[125] Urakov A.L., Urakova N.A., et al. COVID-19: Artificial sputum, respiratory obstruction method and screening of pyolitic and antihypoxic drugs // BioImpacts. 2022. Vol. 12, No. 4. P. 393–394. DOI: 10.34172/bi.2022.23877

[126] Urakov AL, Urakova NA. COVID-19: Optimization of respiratory biomechanics by aerosol pus solvent. Russian Journal of Biomechanics. 2021;25(1):86–90. DOI: 10.15593/RJBiomech/2021.1.07

[127] Ураков А.Л., Уракова Н.А. COVID-19: Оптимизация биомеханики дыхания аэрозолем растворителя гноя // Российский журнал биомеханики. 2021. Т. 25, № 1, С. 99–104. DOI: 10.15593/RZhBiomeh/2021.1.07.

[128] Urakov АL, Urakova NA. COVID-19: intrapulmonary injection of hydrogen peroxide solution eliminates hypoxia and normalizes respiratory biomechanics. Russian Journal of Biomechanics. 2021;25(4):350–356. DOI: 10.15593/RJBiomech/2021.4.06

[129] Ураков А.Л. Уракова Н.А. COVID-19: Применение внутрилегочной инъекции раствора перекиси водорода для устранения гипоксии и нормализации биомеханики дыхания при респираторной обструкции // Российский журнал биомеханики. 2021. Т. 25, № 4. С. 406–413. DOI: 10.15593/RZhBiomeh/2021.4.06

[130] Urakov AL. COVID-19: Immediate lung reoxygenation with hydrogen peroxide: Reality or fantasy. Advances in Bioresearch. 2021;12(5B):359–363. DOI: 10.15515/abr.0976-4585.12.5B.359363

[131] Urakov A.L. COVID-19: Immediate lung reoxygenation with hydrogen peroxide: Reality or fantasy // Advances in Bioresearch. 2021. Vol. 12, No. 5B. P. 359–363. DOI: 10.15515/abr.0976-4585.12.5B.359363

RIGHTS & PERMISSIONS

ECO-vector